GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma … – RTT News

GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma
RTT News
GlaxoSmithKline plc(GSK: Quote,GSK.L), and Theravance, Inc.(THRX: Quote), Friday said that Relvar Ellipta for the treatment of bronchial asthma got approval from the Japanese Ministry of Health, Labour and Welfare. The company said Relvar Ellipta is
Japan approves lung drugs from GSK/Theravance and SkyePharmaReuters
Glaxo's Relvar Lung Treatment Recommended by EU RegulatorBloomberg
GlaxoSmithKline Treatments Given Positive Opinion In Europe, Approved in JapanLondon South East

all 8 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.